The posters are available on the Posters and Publications page of the Company’s website.

JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; "JCR") announced today that the Company presented preclinical data from its novel adeno-associated virus (AAV) gene ...

Nvelop Therapeutics, a biotechnology company engineering programmable, non-viral vehicles for the in vivo delivery of ...

Two oral presentations and nine poster presentations will highlight exciting progress in AskBio’s clinical and pre-clinical ...

Data further validates the AnelloVector™ platform as the first gene delivery vector system based on the human commensal anellovirusCAMBRIDGE, ...

at the European Society of Gene and Cell Therapy (ESGCT) 31st Annual Meeting taking place October 22–25, 2024, in Rome, Italy. “Our presence at ESCGT this year demonstrates our commitment to ...

Posters feature innovative technologies that address limitations of gene therapy production LAUSANNE, SWITZERLAND, October 17, 2024 ...

announced the presentation of three posters at the European Society of Gene and Cell Therapy (ESGCT) 31st Annual Congress, taking place from October 22-25, 2024, in Rome, Italy. Amplo will feature ...